A vaccine certificate and a negative COVID-19 test result will be compulsory for domestic travel during the Christmas and New Year holidays, Head of Health Handling at the COVID-19 Task
Energy and Mineral Resources Minister Arifin Tasrif has said that his ministry is currently preparing a strategic plan for developing Biodiesel 40 (B40), which contains 40 percent biofuel and 60
Aceh provincial police have thwarted an attempt by a drug-trafficking syndicate to distribute 100 kilograms of crystal methamphetamine in Indonesia and arrested three suspected members of the syndicate. “They were
The upstream oil and gas industry will continue to support the availability of affordable energy supplies and create economic growth in Indonesia, Coordinating Minister for Economic Affairs, Airlangga Hartarto, has
Indonesia has not imported any rice in 2021 and the nation’s current rice stocks are also adequate to meet domestic demand, President Joko Widodo (popularly known as Jokowi) has said.
Parents should ensure children get complete routine vaccinations before obtaining the COVID-19 vaccine, according to chairperson of the Indonesian Technical Advisory Group on Immunization (ITAGI), Prof. Sri Rezeki Hadinegoro. “This
The government has again raised the public activities restrictions (PPKM) status in Jakarta to Level 2, which will remain in effect from Tuesday (November 30, 2021) till Monday (December 13,
The National Research and Innovation Agency (BRIN) will continue to focus on health research and innovation activities for the handling and mitigation of COVID-19, BRIN Head Laksana Tri Handoko has said. “At
4th approved indication for toripalimab SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab in combination with cisplatin and
SAN DIEGO and BASEL, Switzerland, Nov. 29, 2021 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune disease, today announced that it has appointed Jacob Chacko, M.D., as Chair of its Board of Directors. Dr. Chacko currently serves as President, CEO